Keyphrases
Hemodialysis Patients
100%
Growth Hormone
100%
Cardiovascular Effects
100%
Randomized Controlled Trial
100%
Insulin-like Growth factor-1
50%
Cardiovascular Risk Markers
50%
Placebo
50%
Lean Body Mass
33%
Growth Hormone Treatment
33%
Left Ventricular Mass
16%
IGF-I Level
16%
Logistic Regression Analysis
16%
Morbidity Rate
16%
Echocardiography
16%
Low-density Lipoprotein Cholesterol (LDL-C)
16%
All-cause Mortality
16%
High Mortality
16%
Maintenance Hemodialysis Patients
16%
Interleukin-6
16%
Beneficial Effects
16%
Inflammatory Markers
16%
Blood Pressure
16%
Insulin-like Growth Factor Binding protein-3 (IGFBP-3)
16%
Lipid Profile
16%
Change from Baseline
16%
Homocysteine Levels
16%
Plasma Homocysteine
16%
Systolic Blood Pressure
16%
Ghrelin
16%
Adult Patients
16%
High Morbidity
16%
High-density Lipoprotein Cholesterol (HDL-C)
16%
Body Mass Index
16%
Mortality Rate
16%
Biochemistry, Genetics and Molecular Biology
Cardiovascular Effect
100%
Randomized Controlled Trial
100%
Bovine Somatotropin
100%
Hemodialysis
100%
Growth Hormone
100%
Lean Body Weight
25%
Blood Plasma
25%
Homocysteine
25%
Blood Pressure
12%
Low-Density Lipoprotein
12%
Prospective Study
12%
Interleukin 6
12%
Hematocrit
12%
Body Mass
12%
Systolic Blood Pressure
12%
Morbidity
12%
High Density Lipoprotein Cholesterol Level
12%
Ghrelin
12%
Lipid Profile
12%
Heart Left Ventricle Mass
12%
Mortality Rate
12%
All Cause Mortality
12%
Pharmacology, Toxicology and Pharmaceutical Science
Randomized Controlled Trial
100%
Hemodialysis
100%
Growth Hormone
100%
Cardiovascular Disease
50%
Placebo
37%
Homocysteine
25%
High Density Lipoprotein Cholesterol
12%
Low Density Lipoprotein Cholesterol
12%
All Cause Mortality
12%
Interleukin 6
12%
Mortality Rate
12%
Ghrelin
12%
Prospective Study
12%
Morbidity
12%